提尔德拉基祖马布对中度至重度斑块性牛皮的实际益处:从系统文献综述和元分析中得出的发现

相关实验视频

Updated: Jan 13, 2026

Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability
08:22

Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability

Published on: October 7, 2017

8.5K

Scott Gottlieb1, Aaron S Farberg2,3, Neal Bhatia4

  • 1Schweiger Dermatology Group, Exton, PA, USA.

Dermatology and therapy
|January 7, 2026
PubMed
概括

蒂尔德拉基祖马布有效治疗中度至严重的斑块性牛皮 (PsO),显著改善皮肤清除和生活质量,在现实环境中具有有利的安全性. 它的好处与其他先进疗法相当.

关键词:
有效性 有效性.牛皮是一种病.生活质量生活的质量.现实世界的证据.安全的安全的安全的安全的安全.系统性审查 系统性审查提尔德拉基祖马巴姆 (Tildrakizumab) 是一个

更多相关视频

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.4K
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

759

相关概念视频

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
478